| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 09/18/2013 | CN103304618A Triterpenoid saponin compound with anti-inflammatory activity as well as preparation method and application thereof |
| 09/18/2013 | CN101463061B Ginseng saponin Rg1 and Rb1 in pseudo-ginseng and preparation of total saponin thereof |
| 09/11/2013 | CN102216318B 抗氧化剂 Antioxidants |
| 09/04/2013 | CN103275149A Process for extracting chrysanthemum flavone, phenolic acid and triterpene |
| 08/28/2013 | CN103265590A Method for preparing leguminosae I |
| 08/21/2013 | CN102030800B Abies holophylla triterpenoid compound, extraction separation thereof and application thereof |
| 08/14/2013 | CN103242409A Extraction and separation method of polypodium glycoside A |
| 08/14/2013 | CN103242408A Method for extracting ginsenoside monomers Rg3 and Rh2 by microwave assistive technology |
| 08/14/2013 | CN103242394A Method for preparing palustroside |
| 08/14/2013 | CN102481303B Glucose metabolism-improving agent and glucose metabolism-improving composition |
| 08/14/2013 | CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 08/07/2013 | CN103232516A Extracting-separating method of polypodium glycyrrhiza A |
| 08/07/2013 | CN103232515A Cyclocarya paliurus glucoside I preparation method |
| 07/31/2013 | CN102079770B Preparation method of mometasone furoate monohydrate |
| 07/24/2013 | EP2616477A2 6-substituted demethyl-estradiol derivatives as er-beta agonists |
| 07/24/2013 | CN103214536A Polyhydroxy steroidal compounds separated from coral, and application thereof |
| 07/18/2013 | US20130184244 Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof |
| 07/17/2013 | CN101212979B 内脏脂肪蓄积抑制剂 Visceral fat accumulation inhibitor |
| 07/16/2013 | US8486462 Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 07/11/2013 | US20130178431 Glycoside compounds and pharmaceutical compositions thereof |
| 07/10/2013 | CN103193848A Pseudoginsenoside RT6 and extraction method thereof, and applications of pseudoginsenoside RT6 drug |
| 07/10/2013 | CN103193847A Pseudoginsenoside R1 and extraction method thereof, and applications of pseudoginsenoside R1 drug |
| 07/10/2013 | CN103193846A Preparation method of cis-trans isomers of ginsenoside Rk3 and ginsenoside Rh4 |
| 07/10/2013 | CN103191187A Uses of different positions of Salvia miltiorrhiza Bunge and Panax Notoginseng and combinations thereof in smooth muscle cell proliferation inhibition and coronary artery restenosis control |
| 07/09/2013 | US8481721 Compositions and methods for increasing telomerase activity |
| 07/04/2013 | WO2013100712A1 Novel blocker for vascular leakage |
| 07/03/2013 | CN103183715A Furostan saponin derivative and purpose thereof |
| 07/02/2013 | CA2742946C Antioxidant |
| 06/25/2013 | US8470774 Deoxycorticosterone induced elastin production |
| 05/29/2013 | CN103122018A Integrated preparation method for mogrosides |
| 05/22/2013 | CN103113449A Aalii saponin compound as well as preparation method and application thereof |
| 05/16/2013 | US20130123223 4-pregenen-11beta-17-21-triol-3,20-dione derivatives |
| 05/16/2013 | CA2854631A1 Indolealkylamino-withasteroid conjugates and method of use |
| 05/09/2013 | US20130116428 Novel poly(ethylene oxide)-block-poly(ester) block copolymers |
| 05/08/2013 | CN103087138A Ginsenoside C-K monohydrate crystal and preparation method thereof |
| 05/08/2013 | CN103087137A Glucocorticoid with sulfoalkyl group at position 21 |
| 05/08/2013 | CN103083368A Preparation method of ginkgo leaf lipoid components having antibacterial activities |
| 05/07/2013 | US8435973 17-beta HSD1 and STS inhibitors |
| 05/01/2013 | CN103073611A Ginsenoside C-K semihydrate crystal and preparation method thereof |
| 05/01/2013 | CN101824065B Fatty-acid monoester compound of ginsenoside secondary glycoside Rh1 and preparation method thereof |
| 05/01/2013 | CN101277705B Agent for amelioration of insulin resistance |
| 04/24/2013 | CN103059089A Method for preparing secondary ginsenoside Rg3 via hydrolyzing primary panaxadiol saponins under catalysis of fresh grape juice |
| 04/24/2013 | CN103059088A Dammarane saponin derivatives with novel structure as well as preparation method and anti-microbial application thereof |
| 04/10/2013 | CN103030678A Method for preparing rare ginsenoside from malonyl ginsenoside |
| 04/10/2013 | CN102260313B Amorphous ginsenoside Rb1 and preparation method thereof |
| 04/10/2013 | CN101575289B Method for separating chemical components of daphne genkwa twigs |
| 04/03/2013 | CN103012537A Dammarane type triterpene compound and preparation method and application thereof |
| 04/03/2013 | CN102627680B Ginsenoside Rg1 compound and pharmaceutical composition containing the same |
| 04/03/2013 | CN101921304B Method for purifying panaxoside compound-K by applying macroporous resin |
| 04/03/2013 | CN101272795B Agent for amelioration of insulin resistance |
| 03/28/2013 | US20130079293 Neuro-protective effects of adelostemma gracillimum and its isolated compounds |
| 03/27/2013 | CN102993258A Method for preparing ginsenoside Rg3 through hydrolyzing total saponins of panax ginseng |
| 03/21/2013 | WO2013040441A1 Plant steroids and uses thereof |
| 03/21/2013 | US20130072698 Method and Compounds for the Preparation of Monofluoromethylated Biologically Active Organic Compounds |
| 03/21/2013 | CA2848979A1 Plant steroids and uses thereof |
| 03/20/2013 | CN102977179A Method for extracting hydroxy group or/and carboxyl group contained natural compounds |
| 03/20/2013 | CN102250184B Amorphous state ginsenoside Rg1 and preparation method thereof |
| 03/20/2013 | CN102030797B Technetium-labeled estradiol derivative and reference compound thereof, and preparation method, application and intermediate thereof |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/13/2013 | CN102964417A Synthetic method of 17-hydroxy tetrahydropyran ether steroid |
| 02/28/2013 | US20130052160 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| 02/27/2013 | CN102942611A Method for preparing high-purity siamenoside I |
| 02/27/2013 | CN102942610A Preparation of ginsenoside M1 n-butyrate and application of antidiabetic medicines of ginsenoside M1 n-butyrate |
| 02/27/2013 | CN102942609A Method for preparing extract with over 50% of picrorhiza saponin II |
| 02/27/2013 | CN101665527B Ginsenoside, preparation method thereof and use thereof |
| 02/21/2013 | US20130046090 Cyclisation process of forming a multiple ring compound |
| 02/14/2013 | US20130040921 Anticancer steroidal lactones unsaturated in position 7 (8) |
| 02/13/2013 | CN102924556A (20S, 24R)-ocotillol type ginsenoside derivative having antibacterial activity and preparation method and application thereof |
| 02/13/2013 | CN102924554A C-3,11,12,20-tetrasubstituted C-21 steroid derivative and its pharmaceutical composition and use in medicine |
| 02/13/2013 | CN102924418A Method for separating and purifying effective ingredients from fine felt hairy honeysuckle |
| 02/06/2013 | CN102911238A Method for preparing C20 position dehydroxylation dammarane type rare ginsenoside and aglycone thereof |
| 02/06/2013 | CN102911237A Method for extracting picfeltrarraenin IA |
| 01/30/2013 | CN102898493A Method for culturing ginseng adventitious roots to produce ginsenosides by using small simple bioreactor |
| 01/22/2013 | CA2670773C 6-alkoxyalkyl estradiol derivatives and methods of use |
| 01/17/2013 | US20130018024 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 01/16/2013 | CN102875628A (20S,24S)-ocotillol ginsenoside derivatives with antibacterial activity, and preparation method and application thereof |
| 01/16/2013 | CN101830965B Method for catalyzing and hydrolyzing natural nucleoside compound by metal ion |
| 01/09/2013 | CN101781353B 20(S)-ginsenoside Rh2 derivatives for regulating and controlling ER Alpha/ER Beta-TNF Alpha channel as well as preparation and anti-tumor application thereof |
| 01/02/2013 | CN102850425A Cynanchum hancockianum glycoside A extraction process |
| 01/02/2013 | CN102329360B Dammar-20S, 25R-epoxy-3beta, 12beta, 26-triol and extraction method and drug use thereof |
| 01/02/2013 | CN102250183B Method for preparing high-purity ginsenoside Re by using ginseng flower buds as raw materials |
| 01/02/2013 | CN101920128B Method for obtaining extractive by solvent extraction method under conditions of pressurization and ultrasonic irradiation |
| 12/25/2012 | US8338628 Method of synthesizing alkylated bile acid derivatives |
| 12/18/2012 | US8334376 Certain chemical entities, compositions, and methods |
| 12/18/2012 | US8334280 Ligands of estrogen receptors α and β, method of their preparation, and pharmaceuticals comprising them |
| 12/06/2012 | US20120309728 New steroid inhibitors of pgp for use for inhibiting multidrug resistance |
| 11/28/2012 | CN102796159A Dammarane glucosides and preparation method and application thereof |
| 11/28/2012 | CN102796157A Caudatin derivative and medicinal composition and application thereof |
| 11/22/2012 | US20120295858 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 11/21/2012 | CN101781351B Method for extracting ginsenoside Rb1 from American ginseng and powder-injection thereof |
| 11/14/2012 | CN102775462A Method for preparing ginsenoside |
| 11/14/2012 | CN102775461A Method for preparing 20 (R)-ginseniside Rg3 |
| 11/14/2012 | CN102775460A Application of ginsenoside Rb3 in preparation of medicine for preventing and curing myocardial remodeling |
| 11/08/2012 | US20120283217 Modulators of amyloid-beta production |
| 11/07/2012 | CN102766187A Ginsenoside Compound-K ester derivative and application thereof to preparation of medicament for prophylaxis and treatment of atherosclerosis |
| 10/31/2012 | EP2517711A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
| 10/31/2012 | CN102391345B Pseuoginsenoside-Rh 2 and application in preparation of tumor treating medicine |
| 10/24/2012 | EP2512485A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance |
| 10/24/2012 | CN102746360A Synthesis and application of four new conjugates of camptothecin-steroid |
| 10/24/2012 | CN102746357A Technology for synthesizing reduced steroid |